Ring Vaccination and Contact Tracing: How Ebola Outbreaks Are Contained

Why Ebola Is Theoretically Containable

Unlike influenza or COVID-19, Ebola does not spread through the air. It requires direct physical contact with the body fluids of a symptomatic person. This means that if every infected person can be identified, isolated, and their contacts vaccinated and monitored, transmission chains can be broken.

This is the theoretical basis for Ebola containment. In practice, achieving it requires two interconnected strategies working simultaneously:

1. Contact tracing: finding everyone who had contact with a confirmed case
2. Ring vaccination: vaccinating those contacts before they develop disease

Together, these two strategies form the backbone of every successful Ebola outbreak response.

Contact Tracing: The Foundation of Outbreak Control

What Is Contact Tracing?

Contact tracing involves systematically identifying every person who had any physical contact with a confirmed Ebola case during their infectious period (from symptom onset through death or discharge). A “contact” is defined as anyone who:

• Lived in the same household as a confirmed case
• Had direct physical contact (touching, providing care, sexual contact) with the case or their body fluids
• Attended the funeral and had contact with the deceased’s body
• Was a healthcare worker who provided care without full PPE
• Had any other direct physical exposure

The 21-Day Follow-Up

Because Ebola’s maximum incubation period is 21 days, every identified contact must be monitored daily for 21 days after their last exposure. During each daily visit or call, a contact tracer assesses for symptoms (fever, headache, fatigue, vomiting, diarrhoea).

If any symptoms develop, the contact is immediately:

• Isolated in a designated facility
• Tested for Ebola
• Moved to an Ebola Treatment Centre if positive

A contact who completes 21 symptom-free days is discharged from surveillance.

Scale in Practice

In the 2018–2020 DRC Kivu outbreak at its peak, over 150,000 contacts were registered in the contact tracing database. On any given day, thousands of daily follow-up visits were occurring across 29 health zones. This required over 1,000 contact tracers working across an area the size of Belgium.

In the 2026 DRC outbreak, the current contact list stands at approximately 412 monitored contacts.

The Problem of Lost-to-Follow-Up Contacts

In any large contact tracing operation, a percentage of contacts will be lost to follow-up — they move away, refuse monitoring, or cannot be located. These “LTFU” contacts are the greatest threat to outbreak control: a missed contact who develops Ebola and spreads it before being identified can seed new transmission chains.

In the DRC Kivu outbreak, up to 10–15% of contacts were lost to follow-up at certain points. In the current 2026 outbreak, 12 contacts were LTFU as of WHO Situation Report #3.

Ring Vaccination: Creating a Protective Barrier

The Concept

Ring vaccination is a targeted vaccination strategy in which, instead of mass vaccination of an entire population, only the people most at risk are vaccinated: the contacts of confirmed cases and the contacts of those contacts (second-ring contacts).

This creates a protective “ring” around each case, preventing the virus from spreading outward. The strategy was originally used to eradicate smallpox in the 1970s.

The Evidence: Ebola Ça Suffit Trial

The pivotal evidence for Ebola ring vaccination came from the Ebola Ça Suffit (“Ebola, That’s Enough”) randomised trial conducted in Guinea during the 2014–2016 West Africa epidemic.

The trial compared:

• Immediate ring vaccination: contacts vaccinated within 0–3 days of case identification
• Delayed ring vaccination: contacts vaccinated 21 days later (effectively unvaccinated during the study window)

Results published in The Lancet (2017):

• Immediate vaccination arm: 0 cases in 2,108 vaccinated individuals after the two-week post-vaccination window (100% efficacy)
• Delayed vaccination arm: 16 cases

This was one of the strongest efficacy results ever seen in a vaccine trial — 100% (95% CI: 63.5%–100%).

How Ring Vaccination Works Operationally

1. A case is confirmed positive by RT-PCR
2. The contact tracing team immediately draws up a list of all contacts (first ring)
3. The vaccination team contacts each person on the list
4. Consent is obtained and rVSV-ZEBOV is administered as a single dose
5. Contacts-of-contacts (second ring) are also vaccinated within 48–72 hours of case confirmation
6. All vaccinees are monitored for adverse events (rVSV-ZEBOV can cause fever, joint pain, and rash in ~30–40% of recipients)

The rVSV-ZEBOV vaccine provides protection within 10 days — faster than any other Ebola vaccine candidate. This speed is critical because contacts may have been exposed only days before vaccination.

Coverage Targets

WHO considers ≥80% ring vaccination coverage (of identified first- and second-ring contacts) sufficient to prevent major outbreak amplification. In the 2026 DRC outbreak, ring vaccination coverage was reported at 87% as of May 2026 — above target.

The Interaction Between Tracing and Vaccination

Contact tracing and ring vaccination are inseparable. The vaccination list is generated by contact tracing — without knowing who the contacts are, you don’t know who to vaccinate. Conversely, vaccinators can support contact tracing by identifying additional contacts through household visits.

This integration requires careful operational coordination:

• Case investigation: within 24 hours of case confirmation
• Contact listing: completed within 48 hours
• Vaccination deployment: ideally within 72 hours of case confirmation

Any delay in this pipeline allows contacts to potentially develop and transmit disease before vaccination protection is established.

Challenges in the Field

Armed Conflict and Access

The eastern DRC is affected by over 100 armed groups. Response teams cannot safely access some areas, meaning both contact tracing and vaccination coverage have geographic blind spots.

Community Resistance

During the 2018–2020 Kivu outbreak, multiple Ebola Treatment Centres were attacked and destroyed by community members who believed — falsely — that ETCs were spreading the disease or that international responders were profiting from it. This led some people to hide cases and avoid contact tracers.

Community engagement — hiring local community leaders and healthcare workers, addressing misinformation, and building trust — is a prerequisite for effective contact tracing, not an add-on.

Nomadic and Mobile Populations

In border areas of DRC, Uganda, Rwanda, and Burundi, population movements are constant. A contact may cross into a neighbouring country before being identified, requiring cross-border coordination of contact tracing.

Scale of Contact Networks

In urban settings, a single case may have dozens or hundreds of contacts (markets, churches, workplaces). Urban Ebola response is categorically harder than rural village containment.

Contact Tracing Technology

Modern contact tracing uses purpose-built digital tools:

• Go.Data (WHO): Open-source contact tracing platform used in DRC and multiple African countries
• KoboToolbox: Data collection platform used for contact follow-up
• OpenHDS: Demographic surveillance system

These tools allow real-time monitoring of contact status, automated alerts for overdue visits, and geographic mapping of contact locations.

Conclusion

Ring vaccination and contact tracing are the closest thing to a proven playbook for Ebola outbreak control. When deployed rapidly, with high coverage, and with community trust, they have ended multiple outbreaks in weeks. The challenge is that “rapidly” and “high coverage” and “community trust” are extremely difficult to achieve simultaneously in the conflict-affected, resource-limited settings where most Ebola outbreaks occur.

The current 2026 DRC outbreak is testing this system again in North Kivu. The response’s 87% vaccination coverage and 412 monitored contacts represent a functioning containment effort — but the 12 lost-to-follow-up contacts remain the greatest near-term risk.